Evidence map›Paper›PMID 35218279›Full record

SynthesisReviews in medical virology2022

Comparative effectiveness of N95, surgical or medical, and non-medical facemasks in protection against respiratory virus infection: A systematic review and network meta-analysis.

Min Seo Kim, Dawon Seong, Han Li, Seo Kyoung Chung, Youngjoo Park, Minho Lee, Seung Won Lee, Dong Keon Yon, Jae Han Kim, Keum Hwa Lee and 22 more

Open access · greenAbstract readSystematic ReviewNetwork Meta-Analysis
In one paragraph

Synthesis in Reviews in medical virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Antiviral Effect ofCurrent pharmaceutical biotechnology · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Effect of Face Masking on Transmission of SARS-CoV-2.Advances in experimental medicine and biology · 2024
    Article
  17. AMMI Canada 2023 update on influenza: Management and emerging issues.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2023
    Article
  18. Article
  19. Review
  20. Changes in the national prevalence of asthma and coronavirus disease 2019 fatality: A population-based cross-sectional study.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 11 countries.

Min Seo KimSamsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
Dawon SeongCollege of Medicine, Yonsei University, Seoul, Republic of Korea.ORCID 0000-0002-0364-3672
Han LiCollege of Medicine, University of Florida, Gainesville, Florida, USA.
Seo Kyoung ChungCollege of Medicine, Ewha Womans University, Seoul, Republic of Korea.
Youngjoo ParkCollege of Medicine, Yonsei University, Seoul, Republic of Korea.
Minho LeeCollege of Medicine, Yonsei University, Seoul, Republic of Korea.
Seung Won LeeDepartment of Data Science, Sejong University College of Software Convergence, Seoul, Republic of Korea.
Dong Keon YonDepartment of Pediatrics, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
Jae Han KimCollege of Medicine, Yonsei University, Seoul, Republic of Korea.
Keum Hwa LeeCollege of Medicine, Yonsei University, Seoul, Republic of Korea.
Marco SolmiDepartment of Psychiatry, University of Ottawa, Ontario, Canada.
Elena DragiotiPain and Rehabilitation Centre and Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Ai KoyanagiResearch and Development Unit, Parc Sanitari Sant Joan de Déu, Universitat de Barcelona, Fundació Sant Joan de Déu, CIBERSAM, Barcelona, Spain.
Louis JacobResearch and Development Unit, Parc Sanitari Sant Joan de Déu, Universitat de Barcelona, Fundació Sant Joan de Déu, CIBERSAM, Barcelona, Spain.
Andreas KronbichlerDepartment of Medicine, University of Cambridge, Cambridge, UK.
Kalthoum TizaouiDepartment of Basic Sciences, Medicine Faculty of Tunis, Tunis El Manar University, Tunis, Tunisia.
Sarah CargninDepartment of Pharmaceutical Sciences, Interdepartmental Research Center of Pharmacogenetics and Pharmacogenomics (CRIFF), University of Piemonte Orientale, Novara, Italy.
Salvatore TerrazzinoDepartment of Pharmaceutical Sciences, Interdepartmental Research Center of Pharmacogenetics and Pharmacogenomics (CRIFF), University of Piemonte Orientale, Novara, Italy.
Sung Hwi HongSeverance Hospital, Yonsei University Health Systems, Seoul, Republic of Korea.
Ramy Abou GhaydaUrology Institute, University Hospitals System, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.ORCID 0000-0002-5170-3983
Joaquim RaduaInstitut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Mental Health Research Networking Center, CIBERSAM, Barcelona, Spain.
Hans OhSchool of Social Work, University of Southern California, California, USA.
Karel KostevUniversity Clinic of Marburg, Marburg, Germany.
Shuji OginoCancer Immunology and Cancer Epidemiology Programs, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts, USA.
I-Min LeeDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Edward GiovannucciDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Yvonne BarnettSchool of Life Sciences, Faculty of Science and Engineering, Anglia Ruskin University, East Road, Cambridge, UK.
Laurie ButlerFaculty of Science and Engineering, Anglia Ruskin University, Cambridge, UK.
Daragh McDermottNTU Psychology, School of Social Sciences, Nottingham Trent University, Nottingham, UK.
Petre-Cristian IlieQueen Elizabeth Hospital Foundation Trust, King's Lynn, UK.
Jae Il ShinCollege of Medicine, Yonsei University, Seoul, Republic of Korea.
Lee SmithCenter for Health, Performance, and Wellbeing, Anglia Ruskin University, Cambridge, UK.
Yonsei University · KRAnglia Ruskin University · GBUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITBrigham and Women's Hospital · USBroad Institute · USEwha Womans University · KRHarvard University · USInstitució Catalana de Recerca i Estudis Avançats · ESKing's College London · GBKyung Hee University Medical Center · KRLinköping University · SENottingham Trent University · GBPhilipps University of Marburg · DEQueen Elizabeth Hospital King's Lynn NHS Foundation Trust · GBSamsung Medical Center · KRSejong University · KRSeverance Hospital · KRTunis El Manar University · TNUniversité de Versailles Saint-Quentin-en-Yvelines · FRUniversity Hospitals of Cleveland · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this systematic review and network meta-analysis is to evaluate the comparative effectiveness of N95, surgical/medical and non-medical facemasks as personal protective equipment against respiratory virus infection. The study incorporated 35 published and unpublished randomized controlled trials and observational studies investigating specific mask effectiveness against influenza virus, SARS-CoV, MERS-CoV and SARS-CoV-2. We searched PubMed, Google Scholar and medRxiv databases for studies published up to 5 February 2021 (PROSPERO registration: CRD42020214729). The primary outcome of interest was the rate of respiratory viral infection. The quality of evidence was estimated using the GRADE approach. High compliance to mask-wearing conferred a significantly better protection (odds ratio [OR], 0.43; 95% confidence interval [CI], 0.23-0.82) than low compliance. N95 or equivalent masks were the most effective in providing protection against coronavirus infections (OR, 0.30; CI, 0.20-0.44) consistently across subgroup analyses of causative viruses and clinical settings. Evidence supporting the use of medical or surgical masks against influenza or coronavirus infections (SARS, MERS and COVID-19) was weak. Our study confirmed that the use of facemasks provides protection against respiratory viral infections in general; however, the effectiveness may vary according to the type of facemask used. Our findings encourage the use of N95 respirators or their equivalents (e.g., P2) for best personal protection in healthcare settings until more evidence on surgical and medical masks is accrued. This study highlights a substantial lack of evidence on the comparative effectiveness of mask types in community settings.

Indexed as

COVID-19Respiratory Tract InfectionsHumansMasksSARS-CoV-2coronavirusCOVID-19facemaskinfluenza virusnetwork meta-analysis

Identifiers

PMID35218279
PMCPMC9111143
OpenAlexW4214554725

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.